PPG to Predict Ejection Fraction and Other Echographic Data in the General Population
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-120
SponsorTulane University
About this trial
The investigators are aiming to investigate the association between ejection fraction (EF) determined by echocardiography and signals obtained from Photoplethysmography (PPG) in the general population. The investigators are also aiming to investigate the association between blood pressure and signals obtained from PPG in the general population.
Finally, the investigators are also aiming to investigate the association between signals obtained from PPG in the general population to cardioechographic findings such as, valvular heart disease, structural heart diseases, cardiomyopathies, pericardial disease etc.
Eligibility criteria
Qualifiers
Male or Female aged18 years or older.
Patients scheduled to undergo an echocardiogram at Tulane Medical Center.
Disqualifiers
Participants under 18 years of age.
Participants with cognitive impairments.
Participants with a physical inability to wear the Biostrap during the echocardiogram.
Individuals who cannot read, speak, and/or understand English.
Trial design
Treatments tested in this trial
- Photoplethysmography
Treatment groups
500 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov